MedTech Dive September 25, 2024
Michelle Brennan was named acting CEO of the patient monitoring company following Joe Kiani’s defeat in a proxy battle with an activist investor.
Dive Brief:
- Masimo CEO and founder Joe Kiani resigned from the company after losing his board seat last week in a proxy battle with Politan Capital Management.
- Former Johnson & Johnson executive Michelle Brennan, who was elected to Masimo’s board last year with Politan’s support, was named interim CEO effective immediately, according to a Wednesday announcement.
- Masimo reaffirmed its financial guidance for the third quarter on a non-GAAP basis. CFO Micah Young and Chief Operating Officer Bilal Muhsin said they would provide more details on an earnings call in October.
Dive Insight:
Kiani’s resignation 35...